305 related articles for article (PubMed ID: 28653787)
1. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.
Butenko T; Jeverica S; Orel R; Homan M
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28653787
[TBL] [Abstract][Full Text] [Related]
2. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Kotilea K; Iliadis E; Nguyen J; Salame A; Mahler T; Miendje Deyi VY; Bontems P
Helicobacter; 2023 Oct; 28(5):e13006. PubMed ID: 37402147
[TBL] [Abstract][Full Text] [Related]
4. Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Bontems P; Kalach N; Oderda G; Salame A; Muyshont L; Miendje DY; Raymond J; Cadranel S; Scaillon M
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):646-50. PubMed ID: 21701406
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
[TBL] [Abstract][Full Text] [Related]
6. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
7. Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children.
Kotilea K; Mekhael J; Salame A; Mahler T; Miendje-Deyi VY; Cadranel S; Bontems P
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28303625
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
Nguyen TC; Le GKN; Pham DTH; Pham BV; Nguyen LTH; Che TH; Nguyen HT; Truong DQ; Robert A; Bontems P; Nguyen PNV
Helicobacter; 2023 Oct; 28(5):e13009. PubMed ID: 37497797
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-resistant Helicobacter pylori strains in Portuguese children.
Lopes AI; Oleastro M; Palha A; Fernandes A; Monteiro L
Pediatr Infect Dis J; 2005 May; 24(5):404-9. PubMed ID: 15876938
[TBL] [Abstract][Full Text] [Related]
10. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
[TBL] [Abstract][Full Text] [Related]
11. Primary antibiotic resistance and effectiveness of Helicobacter pylori triple therapy in ulcero-inflammatory pathologies of the upper digestive tract.
Aguemon B; Struelens M; Devière J; Denis O; Golstein P; Salmon I; Nagy N
Acta Gastroenterol Belg; 2005; 68(3):287-93. PubMed ID: 16268413
[TBL] [Abstract][Full Text] [Related]
12. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
13. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China.
Shu X; Yin G; Liu M; Peng K; Zhao H; Jiang M
Helicobacter; 2018 Jun; 23(3):e12481. PubMed ID: 29528162
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.
Hojsak I; Kos T; Dumančić J; Mišak Z; Jadrešin O; Jaklin Kekez A; Lukić Grlić A; Kolaček S
Eur J Pediatr; 2012 Sep; 171(9):1325-30. PubMed ID: 22430353
[TBL] [Abstract][Full Text] [Related]
17. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ
Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754
[TBL] [Abstract][Full Text] [Related]
18. Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.
Shu X; Ye D; Hu C; Peng K; Zhao H; Li H; Jiang M
Sci Rep; 2022 Oct; 12(1):17754. PubMed ID: 36272980
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure.
Yahav J; Shmuely H; Niv Y; Bechor J; Samra Z
Diagn Microbiol Infect Dis; 2006 May; 55(1):81-3. PubMed ID: 16490341
[TBL] [Abstract][Full Text] [Related]
20. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]